Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H101 (Oncorine) +/- Radiotherapy in Gynecological Malignancies
NCT05051696Phase 2Active, not recruiting
- Start
- Sep 2021
- Primary completion
- Mar 2024
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of Oncorine in gynecological cancer. Started Sep 2021; status: active, not recruiting.
02
Drugs
Oncorine
03
Conditions
gynecological cancer
Beyond the preview
Go deeper on NCT05051696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05051696.